UCLA has extended athletic director Martin Jarmond’s contract through 2029, the school announced in a press release Thursday ...

Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that ...

Valued at a market cap of $30.3 billion, Dublin, Ohio-based Cardinal Health, Inc. (CAH) is a healthcare services and products ...

Cardinal Health has entered into definitive agreements to acquire two companies as the medical supply firm and drug ...

Cardinal Health CAH recently announced that it has entered into definitive agreements to acquire two companies. These ...

Court Square Capital Partners has agreed to sell Advanced Diabetes Supply Group, a Carlsbad, California-based distributor of durable medical equipment specializing in diabetes supplies, to Cardinal ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

Wells Fargo analyst Steve Baxter maintained a Sell rating on Cardinal Health (CAH – Research Report) yesterday and set a price target of $101.00. The company’s shares closed yesterday at $123.51.

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target remains the same with $127.00. Erin Wright has given his ...

Cardinal Health plans acquisitions to anchor its new territory managing specialty physician groups and expand its home-care ...

Cardinal Health has agreed to acquire a majority stake in GI Alliance, a gastroenterology management services organization, and Advanced Diabetes Supply Group for a combined total of $3.9 billion, ...